Study Overview
Details
NCTId: NCT02803957
Status: Recruiting
Condition: Mitral Valve Insufficiency
Study Type: Interventional
Sponsor: NeoChord
Study Description
Brief
The objective of this trial is to assess the safety and effectiveness of the study device in subjects with degenerative mitral valve disease receiving a mitral valve repair without cardiopulmonary bypass (treatment group) when compared to subjects receiving mitral valve repair using standard surgical techniques with cardiopulmonary bypass (control group).
Eligibility
Criteria:
Inclusion Criteria:
Is a candidate for mitral valve repair with cardiopulmonary bypass
Has Grade III moderate or Grade IV severe degenerative mitral valve regurgitation
Primary segmental prolapse of the A2 or P2 segment or prolapse extending to an adjacent segment (P1, P3, A1, A3) who have a single eccentric regurgitant jet on echocardiogram
Anterior leaflet covers at least 65% of anterior-posterior annular distance or an anterior leaflet that would provide sufficient coaptation after chord placement
Anatomic and general suitability
Exclusion Criteria:
Prior mitral valve surgery
Concomitant cardiac procedures
Other cardiac procedures within 3 months
Healthy Volunteers: No
Gender: All
Min Age: 21 Years
Contacts
Valley Health System | Virginia
Recruiting
Winchester
Virginia
22601
United States
Basel Ramlawi, MD
Principal Investigator
